Madrid, Spain

Pedro Cueva Sànchez

This inventor holds 1 USPTO granted patent. Top assignee: Amderma Pharmaceuticals, LLC. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pedro Cueva Sànchez. Retrieved from https://idiyas.com/inventor/pedro-cueva-sànchez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pedro Cueva Sànchez: Innovator in Dermatological Treatments

Introduction

Pedro Cueva Sànchez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of dermatology through his innovative research and development. His work focuses on the therapeutic applications of chemical compounds for treating skin conditions.

Latest Patents

Pedro holds a patent for the "Use of 2,5-dihydroxybenzene derivatives for treating dermatitis." This invention relates to the use of a 2,5-dihydroxybenzene derivative represented by Formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the therapeutic and/or prophylactic treatment of dermatitis. This patent highlights his commitment to advancing medical treatments for skin ailments.

Career Highlights

Pedro is currently associated with Amderma Pharmaceuticals, LLC, where he continues to develop innovative solutions for dermatological issues. His expertise in the field has positioned him as a key player in the pharmaceutical industry, particularly in the area of skin treatment.

Collaborations

Throughout his career, Pedro has collaborated with esteemed colleagues such as Guillermo Gimenez Gallego and Inigo Saenz De Tejada Gorman. These partnerships have fostered a collaborative environment that enhances the development of effective treatments.

Conclusion

Pedro Cueva Sànchez is a dedicated inventor whose work in dermatology is paving the way for new therapeutic options. His patent on 2,5-dihydroxybenzene derivatives exemplifies his innovative spirit and commitment to improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…